76754 Federal Register / Vol. 75, No. 236 / Thursday, December 9, 2010 / Notices 

Wang (a/k/a Alice B. Wang) of Arcadia, 

CA; Trendy Creations, Inc. of 

Chatsworth, CA; The Inspired Bagger of 

Dallas, TX; and House of Bags of Los 

Angeles, CA. 

The complainant, proposed 

respondents, other interested parties, 

and members of the public are invited 

to file comments, not to exceed five 

pages in length, on any public interest 

issues raised by the complaint. 

Comments should address whether 

issuance of an exclusion order and/or a 

cease and desist order in this 

investigation would negatively affect the 

public health and welfare in the United 

States, competitive conditions in the 

United States economy, the production 

of like or directly competitive articles in 

the United States, or United States 

consumers. 

In particular, the Commission is 

interested in comments that: 

(i) Explain how the articles 

potentially subject to the orders are used 

in the United States; 

(ii) Identify any public health, safety, 

or welfare concerns in the United States 

relating to the potential orders; 

(iii) Indicate the extent to which like 

or directly competitive articles are 

produced in the United States or are 

otherwise available in the United States, 

with respect to the articles potentially 

subject to the orders; and 

(iv) Indicate whether Complainant, 

Complainant’s licensees, and/or third 

party suppliers have the capacity to 

replace the volume of articles 

potentially subject to an exclusion order 

and a cease and desist order within a 

commercially reasonable time. 

Written submissions must be filed no 

later than by close of business, five 

business days after the date of 

publication of this notice in the Federal 

Register. There will be further 

opportunities for comment on the 

public interest after the issuance of any 

final initial determination in this 

investigation. 

Persons filing written submissions 

must file the original document and 12 

true copies thereof on or before the 

deadlines stated above with the Office 

of the Secretary. Submissions should 

refer to the docket number (‘‘Docket No. 

2772’’) in a prominent place on the 

cover page and/or the first page. The 

Commission’s rules authorize filing 

submissions with the Secretary by 

facsimile or electronic means only to the 

extent permitted by section 201.8 of the 

rules (see Handbook for Electronic 

Filing Procedures, http://www.usitc.gov/ 

secretary/fed_reg_notices/rules/ 

documents/ 

handbook_on_electronic_filing.pdf). 

Persons with questions regarding 

electronic filing should contact the 

Secretary (202–205–2000). 

Any person desiring to submit a 

document to the Commission in 

confidence must request confidential 

treatment. All such requests should be 

directed to the Secretary to the 

Commission and must include a full 

statement of the reasons why the 

Commission should grant such 

treatment. See 19 CFR 201.6. Documents 

for which confidential treatment by the 

Commission is properly sought will be 

treated accordingly. All nonconfidential 

written submissions will be available for 

public inspection at the Office of the 

Secretary. 

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and of sections 201.10 and 210.50(a)(4) 

of the Commission’s Rules of Practice 

and Procedure (19 CFR 201.10, 

210.50(a)(4)). 

By order of the Commission. 

Issued: December 6, 2010. 

William R. Bishop, 

Acting Secretary to the Commission. 

[FR Doc. 2010–30951 Filed 12–8–10; 8:45 am] 

BILLING CODE P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 731–TA–841 (Second 

Review)] 

Non-Frozen Apple Juice Concentrate 

From China 

AGENCY: United States International 

Trade Commission. 

ACTION: Termination of five-year review. 

SUMMARY: The subject five-year review 

was initiated in October 2010 to 

determine whether revocation of the 

antidumping duty order on non-frozen 

apple juice concentrate from China 

would be likely to lead to continuation 

or recurrence of material injury. On 

November 15, 2010, the Department of 

Commerce published notice that it was 

revoking the order effective November 

2, 2010, ‘‘{b}ecause the domestic 

interested parties did not participate in 

this sunset review * * *’’ (75 FR 

69628). Accordingly, pursuant to 

section 751(c) of the Tariff Act of 1930 

(19 U.S.C. 1675(c)), the subject review is 

terminated. 

DATES: Effective Date: November 2, 

2010. 

FOR FURTHER INFORMATION CONTACT: 

Mary Messer (202–205–3193), Office of 

Investigations, U.S. International Trade 

Commission, 500 E Street SW., 

Washington, DC 20436. Hearingimpaired individuals are advised that 

information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on 202– 

205–1810. Persons with mobility 

impairments who will need special 

assistance in gaining access to the 

Commission should contact the Office 

of the Secretary at 202–205–2000. 

General information concerning the 

Commission may also be obtained by 

accessing its Internet server (http:// 

www.usitc.gov). 

Authority: This review is being terminated 

under authority of title VII of the Tariff Act 

of 1930; this notice is published pursuant to 

section 207.69 of the Commission’s rules (19 

CFR 207.69). 

By order of the Commission. 

Issued: December 3, 2010. 

Marilyn R. Abbott, 

Secretary to the Commission. 

[FR Doc. 2010–30906 Filed 12–8–10; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Notice of Lodging of Consent Decree 

Under the Residential Lead-Based 

Paint Hazard Reduction Act 

Notice is hereby given that on 

December 3, 2010 a proposed Consent 

Decree in United States v. Combined 

Development Co. I, LLC, et al., Civil 

Action No. 1:10-cv-853 was lodged with 

the United States District Court for the 

Southern District of Ohio. 

The consent decree settles claims 

against the owners and managers of 166 

housing units in nine separate 

properties located in or near Cincinnati, 

Ohio. The claims were brought on 

behalf of the Environmental Protection 

Agency (‘‘U.S. EPA’’) and the 

Department of Housing and Urban 

Development (‘‘HUD’’) under the 

Residential Lead-Based Paint Hazard 

Reduction Act, 42 U.S.C. 4851 et seq. 

(‘‘Lead Hazard Reduction Act’’). The 

United States alleged in the complaint 

that the Defendants failed to make one 

or more of the disclosures or to 

complete one or more of the disclosure 

activities required by the Lead Hazard 

Reduction Act. 

Under the Consent Decree, the 

Defendants will certify that they are 

complying with residential lead paint 

notification requirements. The 

Defendants will submit a plan for 

window replacement work and will 

replace all windows known to or 

believed to contain lead-based paint in 

all residential properties owned or 

managed by Defendants that are not 

certified lead-based paint free. In 


erowe on DSK5CLS3C1PROD with NOTICES
Federal Register / Vol. 75, No. 236 / Thursday, December 9, 2010 / Notices 76755 

addition, Defendants will abate leadbased paint hazards on friction and 

impact surfaces, stabilize other leadbased paint hazards, and pay an 

administrative penalty of $7,500. 

The Department of Justice will receive 

for a period of thirty (30) days from the 

date of this publication comments 

relating to the Proposed Consent Decree. 

Comments should be addressed to the 

Assistant Attorney General, 

Environment and Natural Resources 

Division, and either e-mailed to 

pubcomment-ees.enrd@usdoj.gov or 

mailed to U.S. Department of Justice, 

Washington, DC 20044–7611 P.O. Box 

7611, U.S. Department of Justice, 

Washington, DC 20044–7611, and 

should refer to United States v. 

Combined Development Co. I, LLC, et 

al., D.J. Ref. # 90–5–1–1–09435. 

The Proposed Consent Decree may be 

examined at the Department of Housing 

and Urban Development, Office of 

General Counsel, 451 7th St. NW., Room 

9262, Washington, DC 20410; at the 

office of the United States Attorney for 

the Southern District of Ohio, 303 

Marconi Blvd., Suite 200, Columbus, 

Ohio 43215 (Attn. Assistant United 

States Attorney Andrew M. Malek); and 

at U.S. EPA Region 5, 77 W. Jackson 

Blvd., Chicago, IL 60604. During the 

public comment period, the Consent 

Decree may also be examined on the 

following Department of Justice Web 

site, to http://www.usdoj.gov/enrd/ 

Consent_Decrees.html. A copy of the 

Consent Decree may also be obtained by 

mail from the Consent Decree Library, 

P.O. Box 7611, U.S. Department of 

Justice, Washington, DC 20044–7611 or 

by faxing or e-mailing a request to Tonia 

Fleetwood (tonia.fleetwood@usdoj.gov), 

fax no. (202) 514–0097, phone 

confirmation number (202) 514–1547. In 

requesting a copy from the Consent 

Decree Library, please enclose a check 

in the amount of $9.25 (25 cents per 

page reproduction cost) payable to the 

U.S. Treasury or, if by e-mail or fax, 

forward a check in that amount to the 

Consent Decree Library at the stated 

address. 

Maureen Katz, 

Assistant Chief, Environmental Enforcement 

Section, Environment and Natural Resources 

Division. 

[FR Doc. 2010–30900 Filed 12–8–10; 8:45 am] 

BILLING CODE 4410–15–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to 21 U.S.C. 958(i), the 

Attorney General shall, prior to issuing 

a registration under this Section to a 

bulk manufacturer of a controlled 

substance in schedule I or II, and prior 

to issuing a regulation under 21 U.S.C. 

952(a)(2) authorizing the importation of 

such a substance, provide 

manufacturers holding registrations for 

the bulk manufacture of the substance 

an opportunity for a hearing. 

Therefore, in accordance with 21 CFR 

1301.34(a), this is notice that on October 

19, 2010, Mylan Pharmaceuticals, Inc., 

781 Chestnut Ridge Road, Morgantown, 

West Virginia 26505, made application 

by renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

an importer of the basic classes of 

controlled substances listed in schedule 

II: 

Drug Schedule 

Methylphenidate (1724) ................ II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................ II 

Fentanyl (9801) ............................ II 

The company plans to import the 

listed controlled substances in finished 

dosage form (FDF) from foreign sources 

for analytical testing and clinical trials 

in which the foreign FDF will be 

compared to the company’s own 

domestically-manufactured FDF. This 

analysis is required to allow the 

company to export domesticallymanufactured FDF to foreign markets. 

Any bulk manufacturer who is 

presently, or is applying to be, 

registered with DEA to manufacture 

such basic class of controlled substance 

may file comments or objections to the 

issuance of the proposed registration 

and may, at the same time, file a written 

request for a hearing on such 

application pursuant to 21 CFR 1301.43, 

and in such form as prescribed by 21 

CFR 1316.47. 

Any such comments or objections 

should be addressed, in quintuplicate, 

to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than January 10, 2011. 

This procedure is to be conducted 

simultaneously with, and independent 

of, the procedures described in 21 CFR 

§ 1301.34(b), (c), (d), (e), and (f). As 

noted in a previous notice published in 

the Federal Register on September 23, 

1975, (40 FR 43745–46), all applicants 

for registration to import a basic class of 

any controlled substance in schedule I 

or II are, and will continue to be, 

required to demonstrate to the Deputy 

Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a); 21 U.S.C. 823(a); and 21 

CFR 1301.34(b), (c), (d), (e), and (f) are 

satisfied. 

Dated: November 29, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–30901 Filed 12–8–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated August 3, 2010, and 

published in the Federal Register on 

September 1, 2010, (75 FR 53719), 

Alltech Associates, Inc., 2051 Waukegan 

Road, Deerfield, Illinois 60015, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as an importer of the basic 

classes of controlled substances: 

Drug Schedule 

Gamma Hydroxybutyric Acid 

(2010).

I 

Heroin (9200) ............................... I 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Hydrocodone (9193) ..................... II 

Meperidine (9230) ........................ II 

Methadone (9250) ........................ II 

Morphine (9300) ........................... II 

The company plans to import these 

controlled substances for the 

manufacture of reference standards. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a) 

and determined that the registration of 

Alltech Associates, Inc. to import the 

basic classes of controlled substances is 

consistent with the public interest and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971. DEA 

has investigated Alltech Associates, Inc. 

to ensure that the company’s 

registration is consistent with the public 

interest. The investigation has included 

inspection and testing of the company’s 

physical security systems, verification 


erowe on DSK5CLS3C1PROD with NOTICES